ResMed Historical Cash Flow
| RMD Stock | USD 249.02 0.31 0.12% |
Analysis of ResMed cash flow over time is an excellent tool to project ResMed Inc future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Begin Period Cash Flow of 325.3 M or Depreciation of 227 M as it is a great indicator of ResMed ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining ResMed Inc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether ResMed Inc is a good buy for the upcoming year.
ResMed |
About ResMed Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in ResMed balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which ResMed's non-liquid assets can be easily converted into cash.
ResMed Cash Flow Chart
Add Fundamental
Capital Expenditures
Capital Expenditures are funds used by ResMed Inc to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of ResMed operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in ResMed Inc financial statement analysis. It represents the amount of money remaining after all of ResMed Inc operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Most accounts from ResMed's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into ResMed Inc current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ResMed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. At present, ResMed's Free Cash Flow is projected to increase significantly based on the last few years of reporting. The current year's Change In Working Capital is expected to grow to about 47 M, whereas Other Cashflows From Financing Activities is projected to grow to (9.5 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Dividends Paid | 245.3M | 258.3M | 282.3M | 203.0M | Stock Based Compensation | 65.3M | 71.1M | 80.2M | 40.4M |
ResMed cash flow statement Correlations
Click cells to compare fundamentals
ResMed Account Relationship Matchups
High Positive Relationship
High Negative Relationship
ResMed cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (69.9M) | (22.0M) | (311.7M) | (248.8M) | 172.2M | 180.8M | |
| Change In Cash | 316.0M | (167.9M) | (21.6M) | (45.8M) | 10.5M | 6.5M | |
| Free Cash Flow | 696.3M | 619.9M | 195.1M | 559.3M | 1.3B | 1.4B | |
| Change In Working Capital | (97.9M) | 1.4M | (708.1M) | (462.1M) | 44.8M | 47.0M | |
| Begin Period Cash Flow | 147.1M | 463.2M | 295.3M | 273.7M | 227.9M | 325.3M | |
| Other Cashflows From Financing Activities | (46.4M) | (53.7M) | 235.6M | (33.0M) | (10.1M) | (9.5M) | |
| Depreciation | 181.4M | 191.5M | 193.8M | 197.6M | 216.2M | 227.0M | |
| Other Non Cash Items | (7K) | 8.7M | 20.7M | (11.1M) | 39.1M | 41.1M | |
| Capital Expenditures | 105.9M | 116.8M | 156.0M | 134M | 114.9M | 66.9M | |
| Total Cash From Operating Activities | 802.3M | 736.7M | 351.1M | 693.3M | 1.4B | 1.5B | |
| Net Income | 621.7M | 474.5M | 779.4M | 897.6M | 1.0B | 1.1B | |
| Total Cash From Financing Activities | (317.3M) | (764.6M) | (128.4M) | 422.9M | (1.1B) | (1.1B) | |
| End Period Cash Flow | 463.2M | 295.3M | 273.7M | 227.9M | 238.4M | 334.2M | |
| Sale Purchase Of Stock | 1.2B | 90M | 47.4M | 1.1B | (150.0M) | (142.5M) | |
| Stock Based Compensation | 57.6M | 63.9M | 65.3M | 71.1M | 80.2M | 40.4M | |
| Dividends Paid | 225.1M | 226.7M | 245.3M | 258.3M | 282.3M | 203.0M | |
| Change To Netincome | 82.6M | 69.3M | 85.9M | 60.3M | 69.4M | 45.6M | |
| Change To Liabilities | (23.4M) | 210.7M | (247.6M) | 31.3M | 28.2M | 21.8M | |
| Total Cashflows From Investing Activities | (179.9M) | (158.5M) | (229.9M) | (1.2B) | (1.0B) | (991.7M) | |
| Change To Account Receivables | 54.4M | (129.2M) | 19.3M | (106.5M) | (134.3M) | (127.6M) | |
| Other Cashflows From Investing Activities | (38.5M) | (41.6M) | (17.2M) | (1.0B) | (923.3M) | (877.1M) | |
| Investments | (46.0M) | (158.5M) | (13.9M) | (1.2B) | (269.8M) | (256.3M) | |
| Net Borrowings | (94.0M) | (522M) | 122M | 665M | 764.8M | 803.0M | |
| Change To Operating Activities | (59.0M) | (58.2M) | (168.1M) | (138.1M) | (124.3M) | (118.1M) | |
| Issuance Of Capital Stock | 48.2M | 37.8M | 47.4M | 49.1M | 53.1M | 49.9M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether ResMed Inc is a strong investment it is important to analyze ResMed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ResMed's future performance. For an informed investment choice regarding ResMed Stock, refer to the following important reports:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ResMed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ResMed. If investors know ResMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ResMed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.416 | Dividend Share 1.97 | Earnings Share 7.53 | Revenue Per Share 32.711 | Quarterly Revenue Growth 0.111 |
The market value of ResMed Inc is measured differently than its book value, which is the value of ResMed that is recorded on the company's balance sheet. Investors also form their own opinion of ResMed's value that differs from its market value or its book value, called intrinsic value, which is ResMed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ResMed's market value can be influenced by many factors that don't directly affect ResMed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ResMed's value and its price as these two are different measures arrived at by different means. Investors typically determine if ResMed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ResMed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.